DK0529450T3 - Substituerede mandelsyrederivater som 5-lipoxygenasehæmmere - Google Patents

Substituerede mandelsyrederivater som 5-lipoxygenasehæmmere

Info

Publication number
DK0529450T3
DK0529450T3 DK92113956.4T DK92113956T DK0529450T3 DK 0529450 T3 DK0529450 T3 DK 0529450T3 DK 92113956 T DK92113956 T DK 92113956T DK 0529450 T3 DK0529450 T3 DK 0529450T3
Authority
DK
Denmark
Prior art keywords
acid derivatives
substituted
lipoxygenase inhibitors
almond acid
medicaments
Prior art date
Application number
DK92113956.4T
Other languages
Danish (da)
English (en)
Inventor
Siegfried Dr Raddatz
Christian Dr Kohlsdorfer
Reiner Pro Mueller-Peddinghaus
Klaus-Helmut Dr Mohrs
Michael Dr Matzke
Romanis Fruchtmann
Armin Dr Hatzelmann
Pia Dr Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0529450T3 publication Critical patent/DK0529450T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Measurement Of Force In General (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
  • Moulding By Coating Moulds (AREA)
  • Sewage (AREA)
DK92113956.4T 1991-08-29 1992-08-17 Substituerede mandelsyrederivater som 5-lipoxygenasehæmmere DK0529450T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4128681A DE4128681A1 (de) 1991-08-29 1991-08-29 Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
DK0529450T3 true DK0529450T3 (da) 1995-05-15

Family

ID=6439400

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92113956.4T DK0529450T3 (da) 1991-08-29 1992-08-17 Substituerede mandelsyrederivater som 5-lipoxygenasehæmmere

Country Status (21)

Country Link
US (1) US5292769A (fi)
EP (1) EP0529450B1 (fi)
JP (1) JPH05194402A (fi)
KR (1) KR930004270A (fi)
AT (1) ATE115949T1 (fi)
AU (1) AU643628B2 (fi)
CA (1) CA2076929A1 (fi)
CZ (1) CZ281501B6 (fi)
DE (2) DE4128681A1 (fi)
DK (1) DK0529450T3 (fi)
ES (1) ES2065737T3 (fi)
FI (1) FI101222B1 (fi)
GR (1) GR3015457T3 (fi)
HU (1) HU214577B (fi)
IL (1) IL102949A (fi)
MX (1) MX9204748A (fi)
MY (1) MY110206A (fi)
RU (1) RU2066315C1 (fi)
SK (1) SK263992A3 (fi)
TW (1) TW207995B (fi)
ZA (1) ZA926536B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
US5512581A (en) * 1994-07-18 1996-04-30 Abbott Laboratories Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US8719041B2 (en) * 2002-06-10 2014-05-06 Ebay Inc. Method and system for customizing a network-based transaction facility seller application
TW200410921A (en) * 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
BRPI0417543A (pt) 2003-12-12 2007-03-27 Wyeth Corp quinolinas úteis no tratamento de doença cardiovascular
EP2086531A4 (en) 2006-11-30 2009-09-30 Amira Pharmaceuticals Inc COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS
AU2015214317B2 (en) 2014-02-04 2020-01-16 Bioscience Pharma Partners, Llc Use of FLAP inhibitors to reduce neuroinflammation mediated injury in the central nervous system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Also Published As

Publication number Publication date
HUT67137A (en) 1995-02-28
ZA926536B (en) 1993-03-05
FI923841A0 (fi) 1992-08-27
MY110206A (en) 1998-02-28
US5292769A (en) 1994-03-08
FI923841A (fi) 1993-03-01
MX9204748A (es) 1993-02-01
IL102949A (en) 1997-02-18
AU643628B2 (en) 1993-11-18
CZ263992A3 (en) 1993-08-11
ES2065737T3 (es) 1995-02-16
SK279066B6 (sk) 1998-06-03
EP0529450A1 (de) 1993-03-03
FI101222B (fi) 1998-05-15
EP0529450B1 (de) 1994-12-21
TW207995B (fi) 1993-06-21
RU2066315C1 (ru) 1996-09-10
AU2137192A (en) 1993-03-04
KR930004270A (ko) 1993-03-22
HU9202780D0 (en) 1992-12-28
HU214577B (hu) 1998-04-28
JPH05194402A (ja) 1993-08-03
CZ281501B6 (cs) 1996-10-16
ATE115949T1 (de) 1995-01-15
IL102949A0 (en) 1993-01-31
GR3015457T3 (en) 1995-06-30
FI101222B1 (fi) 1998-05-15
CA2076929A1 (en) 1993-03-01
DE59201013D1 (de) 1995-02-02
SK263992A3 (en) 1998-06-03
DE4128681A1 (de) 1993-03-04

Similar Documents

Publication Publication Date Title
BG101422A (en) Benzoxazole derivatives as bronchodilating compounds
NO933274L (no) Nye estere av bi- og tricykliske aminoalkoholer, samt fremstilling og anvendelse i legemidler
NO301542B1 (no) Nye pyrazin-derivater
AR034120A1 (es) Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico
DK0529450T3 (da) Substituerede mandelsyrederivater som 5-lipoxygenasehæmmere
ES8700673A1 (es) Un procedimiento para preparar derivados de acido griseolico
ES452200A1 (es) Un procedimiento para la preparacion de nuevos derivados de pipendina.
DK0656001T3 (da) Nye 2-substituerede indan-2-mercaptoacetylamid-tricycliske derivater til anvendelse som enkefalinasehæmmere
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
HUT50461A (en) Process for producing imidazole derivatives inhibiting dopamin-beta-hydroxylase and pharmaceutical compositions comprising such compounds
MY108716A (en) New isobutyl-substituted methanesulphonyl-quinolyl- mehtoxyphenyl- cycloalkylacetamides.
GB1219844A (en) Novel 4-oxo-1h-4,5-dihydro-1,2,5-benzotriazepines, processes for their preparation, and compositions incorporating them
JPS51144790A (en) Process for preparing l-cysteine derivatives
ES409217A1 (es) Un procedimiento para la preparacion de derivados de 5-ni- troimidazol.
GB1047911A (en) Glutamine salts
JPS5293755A (en) Preparation of carboxylic acid derivatives
JPS5270020A (en) Fungicidal composition for agriculture and gardening use
JPS52139001A (en) Resolution of racemic organic amines
JPS52118443A (en) Synthesis of 3-methyl-3-(4-isobutylphenyl)pyruvic acid
JPS5350157A (en) Prepration of 2- 4-(1-oxo-2-isoindolinyl)phenyl pyruvic acd
JPS52156996A (en) Preparation of l-tryptophan
JPS53101309A (en) Preparation of 5,6-dihydro-2h-pyran derivative
JPS52156992A (en) Preparation of l-serine
GB973577A (en) Yohimbane derivatives and a process for their preparation
ES377995A1 (es) Procedimiento para la preparacion de nuevos derivados de imidazolidinona.